Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-23

FDA Approved: REGADENOSON — Original Application (International Medication Systems, Limited)

View source ↗

Summary

FDA approved an original ANDA for Regadenoson by International Medication Systems, Limited, authorizing a generic regadenoson product for use as a pharmacologic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Regadenoson (Regadenoson)

Snippet

ORIG AP for REGADENOSON (REGADENOSON)